We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Jazz Pharmaceuticals
JAZZ
$15.6B
| $13.4M | 0.03% |
121,548
+6,057
| +5% | +$670K |
|
477
Atmos Energy
ATO
$27.4B
| $13.4M | 0.03% |
134,447
-18,518
| -12% | -$1.87M |
|
|
AZEK
478
DELISTED
The AZEK Co
AZEK
| $13.4M | 0.03% |
+420,000
| New | +$12.8M |
|
479
AGCO
AGCO
$8.67B
| $13.3M | 0.03% |
240,079
+46,574
| +24% | +$2.43M |
|
480
AXIS Capital
AXS
$7.34B
| $13.3M | 0.03% |
328,024
-5,479
| -2% | -$211K |
|
481
Flowserve
FLS
$9.03B
| $13.3M | 0.03% |
465,747
+12,612
| +3% | +$336K |
|
|
NGHC
482
DELISTED
National General Holdings Corp
NGHC
| $13.3M | 0.03% |
613,663
-461,674
| -43% | -$8.69M |
|
483
Universal Display
OLED
$3.58B
| $13.2M | 0.03% |
88,150
+42,255
| +92% | +$6.2M |
|
484
Agilent Technologies
A
$42.4B
| $13.2M | 0.03% |
148,980
+14,282
| +11% | +$1.17M |
|
485
The RMR Group
RMR
$327M
| $13M | 0.03% |
442,707
+223,512
| +102% | +$6.47M |
|
486
Republic Services
RSG
$68.3B
| $12.9M | 0.03% |
157,398
+40,543
| +35% | +$3.27M |
|
487
Lazard
LAZ
$3.76B
| $12.9M | 0.03% |
450,654
+55,836
| +14% | +$1.51M |
|
|
AVTA
488
DELISTED
Avantax, Inc. Common Stock
AVTA
| $12.7M | 0.03% |
1,112,702
+505,643
| +83% | +$6.35M |
|
489
Invitation Homes
INVH
$16.3B
| $12.7M | 0.03% |
460,922
-44,941
| -9% | -$1.13M |
|
490
Fate Therapeutics
FATE
$282M
| $12.6M | 0.03% |
366,052
-98,462
| -21% | -$2.93M |
|
491
Cigna
CI
$76.3B
| $12.5M | 0.03% |
66,744
+63,026
| +1,695% | +$12M |
|
492
Corpay
CPAY
$26.8B
| $12.5M | 0.03% |
49,670
-19,030
| -28% | -$4.52M |
|
|
POLY
493
DELISTED
Plantronics, Inc.
POLY
| $12.3M | 0.03% |
834,959
+185,267
| +29% | +$2.42M |
|
494
iShares MSCI EAFE ETF
EFA
$77.9B
| $12.2M | 0.03% |
201,000
+43,000
| +27% | +$2.49M |
|
|
MODN
495
DELISTED
MODEL N, INC.
MODN
| $12.2M | 0.03% |
350,473
-280,455
| -44% | -$8.17M |
|
496
Southwest Airlines
LUV
$19.2B
| $12M | 0.03% |
351,741
+312,763
| +802% | +$9.94M |
|
497
SAP
SAP
$249B
| $12M | 0.03% |
85,442
-7,874
| -8% | -$970K |
|
498
Cardinal Health
CAH
$54.1B
| $11.9M | 0.03% |
228,610
+34,736
| +18% | +$1.79M |
|
499
Twist Bioscience
TWST
$9.16B
| $11.8M | 0.03% |
259,998
+91,763
| +55% | +$3.29M |
|
|
AMED
500
DELISTED
Amedisys
AMED
| $11.7M | 0.03% |
59,180
-88,265
| -60% | -$16.5M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.